Jane Armitage is Professor of Clinical Trials & Epidemiology and Honorary Consultant in Public Health Medicine in the Nuffield Department of Population Health (NDPH) at the University of Oxford.  She joined the Clinical Trial Service Unit, now part of NDPH, in 1990 from a background in clinical medicine, with particular experience in respiratory medicine, geriatrics and diabetes.
She has co-ordinated a series of large-scale randomised trials including the MRC/BHF Heart Protection Study, SEARCH and HPS2-THRIVE and ASCEND. Her main research interests are in lipids and the epidemiology of cardiovascular and other chronic disease including osteoporosis. 

She has established and is a Course Director on a University of Oxford Masters (MSc) in Clinical Trials which aims to train the next generation of clinical trialists.


The evolving story of Omega-3 trials and reduction of CVD risk89th EAS Congress 2021(TreatmentTriglycerideLC Omega 3 fatty acidsCVOTHypolipidemic drugs)